alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

115TH CONGRESS 

1ST SESSION S. 118 

To make exclusive the authority of the Federal Government to regulate 

the labeling of products made in the United States and introduced 

in interstate or foreign commerce, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 12, 2017 

Mr. LEE (for himself, Mrs. FISCHER, Mr. KING, Mrs. CAPITO, and Ms. COLLINS) introduced the following bill; which was read twice and referred to 

the Committee on Commerce, Science, and Transportation 

A BILL 

To make exclusive the authority of the Federal Government 

to regulate the labeling of products made in the United 

States and introduced in interstate or foreign commerce, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Reinforcing American5 Made Products Act of 2017’’. 


asabaliauskas on DSK3SPTVN1PROD with BILLS
2 

•S 118 IS

1 SEC. 2. EXCLUSIVITY OF FEDERAL AUTHORITY TO REGU2 LATE LABELING OF PRODUCTS MADE IN THE 

3 UNITED STATES AND INTRODUCED IN INTER4 STATE OR FOREIGN COMMERCE. 

5 Section 320933 of the Violent Crime Control and 

6 Law Enforcement Act of 1994 (15 U.S.C. 45a) is amend7 ed— 

8 (1) in the first sentence, by striking ‘‘To the ex9 tent’’ and inserting the following: 

10 ‘‘(a) IN GENERAL.—To the extent’’; 

11 (2) by adding at the end the following: 

12 ‘‘(b) EFFECT ON STATE LAW.—The provisions of 

13 this section shall supersede any provisions of the law of 

14 any State relating to the extent to which a product is in15 troduced, delivered for introduction, sold, advertised, or 

16 offered for sale in interstate or foreign commerce with a 

17 ‘Made in the U.S.A.’ or ‘Made in America’ label, or the 

18 equivalent thereof, in order to represent that such product 

19 was in whole or substantial part of domestic origin.’’; and 

20 (3) in the third sentence of subsection (a), as 

21 designated by paragraph (1), by striking ‘‘Nothing 

22 in this section’’ and inserting ‘‘Except as provided in 

23 subsection (b), nothing in this section’’. 

Æ 


asabaliauskas on DSK3SPTVN1PROD with BILLS
# C_2018142EN.01004701.xml

| 23.4.2018 | EN | Official Journal of the European Union | C 142/47 |
| --- | --- | --- | --- |

23.4.2018

EN

Official Journal of the European Union

C 142/47

---

Judgment of the General Court of 28 February 2018 — dm-drogerie markt v EUIPO Digital Print Group O. Schimek (Foto Paradies)

(Case T-843/16) (1)

1

((EU trade mark - Invalidity proceedings - EU word mark Foto Paradies - Absolute ground for refusal - Lack of distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009 (now Article 7(1)(b) of Regulation (EU) 2017/1001)))

(2018/C 142/62)

Language of the case: German

Parties

Parties

Applicant: dm-drogerie markt GmbH & Co. KG (Karlsruhe, Germany) (represented by: T. Strack and O. Bludovsky, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: M. Fischer, R. Manea and D. Walicka, acting as Agents)

Defendant:

Other party to the proceedings before the Board of Appeal of EUIPO: Digital Print Group O. Schimek GmbH (Nuremberg, Germany) (represented by: L. Petri and M. Gilch, lawyers)

Other party to the proceedings before the Board of Appeal of EUIPO:

Re:

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 15 September 2016 (R 1194/2015-1), relating to invalidity proceedings between Digital Print Group O. Schimek and dm-drogerie markt.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders dm-drogerie markt GmbH & Co. KG to pay the costs. |
| --- | --- |

2.

Orders dm-drogerie markt GmbH & Co. KG to pay the costs.

---

(1)  OJ C 38, 6.2.2017.

1

---
No. 49088.

#### Protests 78546-K, etc., of T. M. Duche & Sons, Inc., et al. (New York).

Opinion by

Ekwall, J.

In view of Abstract 45762 and stipulation of counsel that the ginger is not composed in chief value of manufactured sugar it was held that the tax under the Sugar Act of 1937 is.not applicable thereto.
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * * VANYA TAYLOR, on behalf of * No. 14

- 146V ZT, a minor child, * Special Master Moran Petitioner, *

* Filed: March 27, 2015

v. *

* Attorneys’ fees and costs; award

SECRETARY OF HEALTH * in the amount to which AND HUMAN SERVICES, * respondent does not object.

* Respondent. *

* * * * * * * * * * * * * * * * * * * * *

Roger A. Johnson , Johnson, Vorhees & Martucci, Joplin, MO, for Petitioner;

Justine Walters , United States Dep’t of Justice, Washington, DC, for Respondent.

UNPUBLISHED DECISION ON FEES AND COSTS 1

On March 27, 2015, respondent filed a stipulation of fact concerning final attorneys’ fees and costs in the above

- captioned matter. Previously, petitioner informally submitted a draft application for attorneys’ fees and costs to respondent for review. Upon review of petitioner’s application, respondent raised objections

to certain items. Bas ed on subsequent discussions, petitioner amended her application to request $18,466.08, an amount to which respondent does not object.

The Court awards this amount.

On February 24, 2014, Vanya Taylor, on behalf of her son, ZT filed a petition for compens ation alleging tetanus - diphtheria

- acellular pertussis (“Tdap”)

vaccine which he received on July 25, 2011 caused him to suffer Guillain -Barré syndrome (“GBS”). Petitioner received compensation based upon the parties’ stipulation. Decision , filed Dec. 29, 2014. Because petitioner received

1 T he E -Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 2002), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website.

1compensation, she is entitled to an award of attorneys’ fees and costs. 42 U.S.C. §

300aa

- 15(e).

Petitioner seeks a total of $18,466.08 in attorneys’ fees and costs for her

counsel. Additionally, in compliance with General Order No. 9, petitioner states

that she incurred no out

- of

- pocket litigation expenses while pursuing this claim. Respondent has no objection to the amount requested for attorneys’ fees and costs.

After reviewing the request, the Court awards the following:

A lump sum of $18,466.08 in the form of a check made payable to petitioner and petitioner’s attorney, Roger A. Johnson, for attorneys’ fees and other litigation costs available under 42 U.S.C. § 300aa -15(e).

The Court thanks the parties for their cooperative efforts in resolving this matter. The Clerk shall enter judgment accordingly.

Any questions may be directed to my law clerk, Christina Gervasi, at (202)

357

- 6521.

IT IS SO ORDERED.

s/Christian J. Moran

Christian J. Moran Special Master

2
EXHIBIT 21
  NAME
    
    STATE OF INCORPORATION/ORGANIZATIONOdyssey HealthCare Holding Company
    
    DEOdyssey HealthCare Operating A, LP
    
    DEOdyssey HealthCare Operating B, LP
    
    DEOdyssey HealthCare Management, LP
    
    DEOdyssey HealthCare GP, LLC
    
    DEOdyssey HealthCare LP, LLC
    
    DEOdyssey HealthCare Fort Worth, LLC
    
    DEOdyssey HealthCare Detroit, LLC
    
    DEOdyssey HealthCare of Collier County, Inc.
    
    DEOdyssey HealthCare of Manatee County, Inc.
    
    DEOdyssey HealthCare of Northwest Florida, Inc
    
    DEOdyssey HealthCare of Hillsborough County, Inc.
    
    DEOdyssey HealthCare of Marion County, Inc
    
    DEOdyssey HealthCare of Pinellas County, Inc
    
    DEOdyssey HealthCare of Austin, LLC
    
    DEOdyssey HealthCare of Augusta, LLC
    
    DEOdyssey HealthCare of Savannah, LLC
    
    DEOdyssey HealthCare of Kansas City, LLC
    
    DEOdyssey HealthCare of St. Louis, LLC
    
    DEVistaCare of Boston, LLC
    
    DEOdyssey HealthCare of South Texas, LLC
    
    DEOdyssey HealthCare of Flint, LLC
    
    DEVistaCare, Inc.
    
    DEVista Hospice Care, Inc.
    
    DEFHI Health Systems, Inc.
    
    DECareNation, Inc.
    
    DEVistaCare USA, Inc.
    
    DEFHI GP, Inc.
    
    TXFHI LP, Inc.
    
    NVFamily Hospice, Ltd.
    
    TXFHI Mangement, Ltd.
    
    TX
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

GAYLORD CASH NEIL, SR. : CIVIL ACTION

:

: NO. 02-4374

 VS. : 

:

MARK SCHWEIKER, ET AL.

 ORDER

AND NOW, this 10th of JULY, 2002, in accordance with the

court’s procedure for random reassignment of cases, it is hereby, 

 ORDERED that the above captioned case is reassigned from the

calendar of the Honorable Edmund V. Ludwig to the Honorable Charles R. Weiner.

FOR THE COURT:

 

JAMES T. GILES

Chief Judge

ATTEST:

 

MICHAEL E. KUNZ

Clerk of Court

Case 2:02-cv-04374-HB Document 2 Filed 07/10/2002 Page 1 of 1
# Official Journal C 170/2006

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 170 |
| | |
| English edition | Information and Notices | Volume 4921 July 2006 |

ISSN 1725-2423

Official Journal

of the European Union

C 170

English edition

Information and Notices

Volume 4921 July 2006

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Court of Auditors |
| 2006/C 170/1 | Special report No 3/2006 concerning the European Commission Humanitarian Aid Response to the Tsunami together with the Commission's replies | 1 |

Notice No

Contents

page

I   Information

Court of Auditors

2006/C 170/1

Special report No 3/2006 concerning the European Commission Humanitarian Aid Response to the Tsunami together with the Commission's replies

1

---

| EN | |
| --- | --- |

EN
<PAGE>

                                  EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with this Quarterly Report on Form 10-Q of Integrated
Healthcare Holdings, Inc. (the "Company") for the quarter ended June 30,
2007, as filed with the Securities and Exchange Commission (the "Report"), the
undersigned, in the capacity and on the date indicated below, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

      (i) the Report fully complies with the requirements of section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934; and

      (ii) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company at the dates and for the period indicated

      This Certificate has not been, and shall not be deemed, "filed" with the
Securities and Exchange Commission.


                                      INTEGRATED HEALTHCARE HOLDINGS, INC.

Dated: August 20, 2007                By:  /s/ Steven R. Blake
                                           ------------------------------
                                           Steven R. Blake
                                           Chief Financial Officer
# Federal **Av iation** 

**Administration** Sm all UAS Certificate of Registration CER TIFICA TE HOLDER: **Lawrence Singer** UAS CER

TIFICA TE NUMBER: 

## FA **3T3AML WM**  ISSUED: 

## 02/12/2016 EX PIRES: 

## 02/12/2019
For U.S. citizens, permanent r esidents, and certain non

- citizen U.S. corporations, this document constitutes a Certificate of Registration. For all others, this document r epr esents a r ecognition of ow nership. For all holders, for all operations other than as a model air craft under sec. 336 of Pub. L. 1 12

- 95, additional safety authority fr om F AA and economic authority fr om DOT may be r

equir ed. **Safety guidelines for**

**flying your**

**unmanned air craft:**  Fly b el ow 400 f

eet Never fly near othe r ai

rcraft Keep your UAS wi

thin visual

line of sight Keep away

f rom emergency responders Never fly over stadiums, sports events or groups of people Never fly under the influence of drugs or alcoho l Never fly wit hin 5 miles of an airport without first conta ct ing air traffic control and airport authori ties
II 

115TH CONGRESS 

1ST SESSION S. 1469 

To amend the Internal Revenue Code of 1986 to extend tax incentives 

to permanently extend the special expensing rules for certain film, television, and live theatrical productions, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

JUNE 28, 2017 

Mr. BLUNT (for himself, Mr. SCHUMER, Mr. ISAKSON, and Mr. CARDIN) introduced the following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To amend the Internal Revenue Code of 1986 to extend 

tax incentives to permanently extend the special expensing rules for certain film, television, and live theatrical 

productions, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Lift Investment in 

5 Film, Television, and Theater Act’’ or the ‘‘LIFTT Act’’. 


lotter on DSKBCFDHB2PROD with BILLS
2 

•S 1469 IS

1 SEC. 2. PERMANENT EXTENSION OF EXPENSING OF QUALI2 FIED PRODUCTIONS. 

3 (a) PERMANENT EXTENSION.—Section 181 of the 

4 Internal Revenue Code of 1986 is amended by striking 

5 subsection (g). 

6 (b) MODIFICATION OF RULES FOR ELECTION.— 

7 Paragraph (1) of section 181(c) of the Internal Revenue 

8 Code of 1986 is amended— 

9 (1) by striking ‘‘for the taxable year in which’’ 

10 and inserting ‘‘for— 

11 ‘‘(1) in the case of a qualified film or television 

12 production, the taxable year in which’’; 

13 (2) by striking the period at the end and insert14 ing ‘‘, and’’; and 

15 (3) by adding at the end the following new 

16 paragraph: 

17 ‘‘(2) in the case of a qualified live theatrical 

18 production, the taxable year in which such theatrical 

19 production holds its first public performance.’’. 

20 (c) EFFECTIVE DATE.— 

21 (1) IN GENERAL.—The amendments made by 

22 this section shall apply to productions commencing 

23 after December 31, 2016. 

24 (2) COMMENCEMENT.—For purposes of para25 graph (1), the date on which a qualified live theat26 rical production commences is the date of the first 


lotter on DSKBCFDHB2PROD with BILLS
3 

•S 1469 IS

1 public performance of such production for a paying 

2 audience. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS
<TABLE> <S> <C>

<PAGE>
<ARTICLE>           5
<LEGEND>
                    The Schedule contains summary financial 
                    information extracted from the financial
                    statements for World Monitor Trust--Series B
                    and is qualified in its entirety by reference
                    to such financial statements
</LEGEND>

<RESTATED>          
<CIK>               1051823
<NAME>              World Monitor Trust--Series B
<MULTIPLIER>        1

<FISCAL-YEAR-END>               Dec-31-1998

<PERIOD-START>                  Jun-10-1998

<PERIOD-END>                    Jun-26-1998

<PERIOD-TYPE>                   1-Mo

<CASH>                          6,071,320

<SECURITIES>                    51,239

<RECEIVABLES>                   14,961

<ALLOWANCES>                    0

<INVENTORY>                     0

<CURRENT-ASSETS>                6,137,520

<PP&E>                          0

<DEPRECIATION>                  0

<TOTAL-ASSETS>                  6,137,520

<CURRENT-LIABILITIES>           25,789

<BONDS>                         0

<PREFERRED-MANDATORY>           0

<PREFERRED>                     0

<COMMON>                        0

<OTHER-SE>                      6,111,731

<TOTAL-LIABILITY-AND-EQUITY>    6,137,520

<SALES>                         0

<TOTAL-REVENUES>                (36,575)

<CGS>                           0

<TOTAL-COSTS>                   0

<OTHER-EXPENSES>                26,483

<LOSS-PROVISION>                0

<INTEREST-EXPENSE>              0

<INCOME-PRETAX>                 0

<INCOME-TAX>                    0

<INCOME-CONTINUING>             0

<DISCONTINUED>                  0

<EXTRAORDINARY>                 0

<CHANGES>                       0

<NET-INCOME>                    (63,058)

<EPS-PRIMARY>                   (1.07)

<EPS-DILUTED>                   0

</TABLE>
Exhibit 15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation
by reference in the Registration Statement (Form F-3, No. 333-182394) of América Móvil, S.A.B. de C.V., of our report dated April 22, 2013, with respect to the effectiveness of internal control over financial reporting of
América Móvil, S.A.B. de C.V., included in this Amendment No. 1 on Form 20-F/A.



Mancera, S.C.A member practice ofErnst & Young Global/s/ Omero Campos SeguraC.P.C. Omero Campos Segura


Mexico City, Mexico

September 2, 2013
# Official Journal C 179E/2006

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 179E |
| | |
| English edition | Information and Notices | Volume 491 August 2006 |

ISSN 1725-2423

Official Journal

of the European Union

C 179E

English edition

Information and Notices

Volume 491 August 2006

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Council |
| 2006/C 179E/1 | Common Position (EC) No 9/2006 of 9 March 2006 adopted by the Council, acting in accordance with the procedure referred to in Article 251 of the Treaty establishing the European Community, with a view to adopting a decision of the European Parliament and of the Council amending Regulation (EEC) No 3922/91 on the harmonisation of technical requirements and administrative procedures in the field of civil aviation | 1 |

Notice No

Contents

page

I   Information

Council

2006/C 179E/1

Common Position (EC) No 9/2006 of 9 March 2006 adopted by the Council, acting in accordance with the procedure referred to in Article 251 of the Treaty establishing the European Community, with a view to adopting a decision of the European Parliament and of the Council amending Regulation (EEC) No 3922/91 on the harmonisation of technical requirements and administrative procedures in the field of civil aviation

1

---

| EN | |
| --- | --- |

EN
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002

In connection with the Annual Report of Duska Therapeutics, Inc. (the Company) on Form 10-KSB, for the fiscal year
ended December 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Mark Reynolds, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and
result of operations of the Company.



|                       
|-----------------------
|/s/ Mark Reynolds      
|Mark Reynolds          
|Chief Financial Officer

March 31, 2006
% Predict blood CPY and urine TCPY levels

% Drinking water concentrations from Orestimba Creek Site 3 120 days.xlsx

% Infants

% Cecilia Tan

% Jan 21, 2016

% Setting model parameters

use human_parameters_MRP

use preg_female_parameters

BWSW=1;% Set BW to a fixed value

BWST=4.8;% Set BW to 4.8 kg

PREG=0;% Not pregnant

DT(1) = 0.0;

TSTOP=2880; % Exposure duration in hrs

%TO READ IN DOSES FROM AN EXCEL SPREADSHEET. must be saved as .xls

VOLUME=0.68557 % Water consumption volume in L/DAY

EVENTS=6 % Drinking frequency per day

DT = xlsRead("Drinkingwater.xls", "Creek", "D2:D722") ; % Dosing Times

AMTCDOSE=xlsRead("Drinkingwater.xls", "Creek", "E2:E722")*VOLUME/EVENTS; % Dose in ug/l

prepare time rbcce cv urinetcpy cvo

start@nocallback

%Output RBC AChE, Urine TCPy, venous blood conc of CPF, venous blood conc of oxon

mytable = [_time _rbcce _urinetcpy _cv*350.6 _cvo*334.5]; % Output unit ug/L for concentrations

save mytable @file='orestimba_infant_01222016.txt' @format=ascii
---

Exhibit 32.1

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, J. Stephen Barley, President, Secretary and
Treasurer of Tuscany Minerals, Ltd., hereby certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

|(1) | the annual report on Form 10-KSB of Tuscany Minerals,
      Ltd. for the year ended December 31, 2007 (the "Report") fully complies
      with the requirements of Section 13(a) or 15(d) of the Securities Exchange
      Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                            
|(2) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of Tuscany Minerals, Ltd.                                                                 

Dated: March 31, 2008

|/s/ J. Stephen Barley                                           | 
|--------------------------------------------------------------- | 
|J. Stephen Barley                                               | 
|President, Secretary and Treasurer                              | 
|(Principal Executive Officer,
      Principal Financial Officer | 
|and Principal Accounting Officer)                               | 

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Tuscany
Minerals, Ltd. and will be retained by Tuscany Minerals, Ltd. and furnished to
the Securities and Exchange Commission or its staff upon request.

---
Before the Second Division,

April 4, 1968

No. P68/190.

protests 61/24013, etc. (New York).

No. P68/191.

protests 64/25119, etc. (New York).

#### Mataichi Corp. *v.*United States, Marmax Trading Corp. *v.*United States,

Rao, C.J.

In accordance with stipulation of counsel that the merchandise covered by the foregoing protests consists of electrical tape, composed wholly or in chief value of vinyl material, similar in all material respects to that the subject of *Devon Tape Corp.*v. *United States*(57 Cust. Ct. 507, C.D. 2856), the claim of the plaintiffs was sustained.